PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.\', \'Vir Biotechnology, San Francisco, CA 94158, USA.\', \'MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.\', \'Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.\', \'Institute of Biodiversity, Animal Health and Comparative Medicine, Boyd Orr Centre for Population and Ecosystem Health, University of Glasgow, Glasgow G61 1QH, UK.\', \'Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3FL, UK.\', \'Molecular Biology Consortium, Advanced Light Source, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.\', \'Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Tri-Institutional PhD Program in Computational Biology and Medicine, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA.\', \'Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.\', \'Cambridge Institute for Medical Research, Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK.\', \'Faculty of Biomedical Sciences, Università della Svizzera italiana, 6900 Lugano, Switzerland; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, 8091 Zurich, Switzerland.\', \'Department of Chemistry and Hamilton Institute, Maynooth University, Maynooth, Ireland.\', \'Department of Nephrology, Ospedale Civico Lugano, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland; Prince of Wales Hospital Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.\', \'Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland; ETH Institute of Microbiology, ETH Zurich, 8093 Zürich, Switzerland.\', \'Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland.\', \'III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, 20157 Milan, Italy.\', \'NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L69 7BE, UK; Respiratory Medicine, Alder Hey Children\'s Hospital, Liverpool L12 2AP, UK.\', \'National Heart and Lung Institute, Imperial College London, London SW3 6LY, UK.\', \'The Roslin Institute, University of Edinburgh, Edinburgh EH25 9RG, UK; Intensive Care Unit, Royal Infirmary Edinburgh, Edinburgh EH16 4SA, UK.\', \'ISARIC4C Investigators.\', \'https://www.cogconsortium.uk.\', \'The Roslin Institute, University of Edinburgh, Edinburgh EH25 9RG, UK.\', \'Vir Biotechnology, San Francisco, CA 94158, USA; Washington University School of Medicine, Saint Louis, MO 63110, USA.\', \'MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK. Electronic address: david.l.robertson@glasgow.ac.uk.\', \'Vir Biotechnology, San Francisco, CA 94158, USA. Electronic address: gsnell@vir.bio.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0092-8674(21)00080-510.1016/j.cell.2021.01.037
?:doi
?:hasPublicationType
?:journal
  • Cell
is ?:pmid of
?:pmid
?:pmid
  • 33621484
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 25.137
?:rankingScore_hIndex
  • 682
?:title
  • Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all